Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001056520-13-000113
Filing Date
2013-05-15
Accepted
2013-05-15 14:34:19
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10Q cellcyteform10qmarch312013fi.htm 10-Q 220653
2 CERTIFICATION exhibit31.htm EX-31 12367
3 CERTIFICATION exhibit32.htm EX-32 5100
  Complete submission text file 0001056520-13-000113.txt   1384107

Data Files

Seq Description Document Type Size
4 INSTANCE ccyg-20130331.xml EX-101.INS 146268
5 SCHEMA ccyg-20130331.xsd EX-101.SCH 7446
6 CALCULATION ccyg-20130331_cal.xml EX-101.CAL 4810
7 DEFINITION ccyg-20130331_def.xml EX-101.DEF 5627
8 LABEL ccyg-20130331_lab.xml EX-101.LAB 85919
9 PRESENTATION ccyg-20130331_pre.xml EX-101.PRE 62096
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

EIN.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52238 | Film No.: 13845964
SIC: 2834 Pharmaceutical Preparations